PREETINDER BRAR: Open Payments
NPI 1851445209 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,742 in 121 payments from 16 companies in 2025. Trend: 2023 $2,021 · 2024 $1,702 · 2025 $2,742
Food & beverage: $2,715Education: $27
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $433 |
| E.R. Squibb & Sons, L.L.C. | 17 | $399 |
| Neurocrine BioSciences, Inc. | 5 | $340 |
| Vanda Pharmaceuticals Inc. | 12 | $292 |
| Janssen Pharmaceuticals, Inc | 8 | $193 |
| ABBVIE INC. | 13 | $189 |
| Bausch Health US, LLC | 11 | $159 |
| Axsome Therapeutics, Inc. | 6 | $156 |
| Supernus Pharmaceuticals, Inc. | 9 | $150 |
| Lundbeck LLC | 6 | $122 |
Products named: REXULTI, COBENFY, INGREZZA, FANAPT, VRAYLAR, INVEGA SUSTENNA, APLENZIN, Auvelity.
Industry payments across NC — which companies pay providers there.
